chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1/20/21 Received shot at 12:00 pm. At 8:00pm I noticed that my gums no longer bled when I flossed and brushed. They have been bleeding since Dec. 1, 2020, and I was diagnosed with Oral Lichen Planus on Dec 8. Following the COVID shot they did not bleed at all for five days, then on the sixth day,  Jan 27, all of my gums blistered and bled a lot. On Jan 28 my dentist and Periodontist diagnosed me with Explosive Oral Lichen Planus.
Pfizer-BioNTech COVID-19 Vaccine EUA  Laughing uncontrollably, slurring of words, headache, fogginess.  Event lasted about one hour.
fever chills body aches, shortness of breath ,  large local lump, reddness, soarness at site of injetion , I was siclkfpr over 10 days my primary physician is aware I had a virtual visit with the NP on Oct 1  I was put on a medrol pack  and albuterol inhalerand also hd a covid test on Oct 2  which was negtive, I had a follow up visit with my primary physician again on Oct 5 , my symptoms hd still not resolved in termss of shortness of breath
Headache, Myalgia, Arthralgia, Fever, Fatigue Narrative: Significant impact on life, as symptoms result in time out of work
This spontaneous report as received from a medical assistant refers to 18 months child patient of unknown gender. The medical assistant stated there was a power outage on 12-APR-2014 and the VARIVAX (Merck) doses from the freezer needed to be transported to unspecified hospital for proper storage. She stated VARIVAX (Merck) was exposed to 46F for 1 hour, at worst. The patient received VARIVAX (Merck) dose 0.5 ml, intramuscularly, lot J006358 expiry 23-MAY-2015, between 12-APR-2014 and 24-APR-2014. There was a site visit from local health department on an unspecified date. No adverse effects was reported. This is one of several reports from the same source. Additional information has been requested.
About 1 and 1/2 minutes after the patient received the vaccine, he knelt down because he felt "like a ton of bricks" and then he passed out. The patient said he started feeling light headed and laid down for a little. He started feeling better and sat down. Patient stated he had not eaten anything that morning. 911 was called as soon as the patient fainted and an ambulance promptly arrived.  Paramedics checked his blood pressure and blood sugar, which was 48. They gave him glucose tabs and his sugar improved. He felt better and did not want to go to the hospital and left on his own.
Dry mouth 15 minutes after injection. BP 150/77 (pulse 89); O2 sat 100%. Albuterol 2 puffs given.
three days after receiving the vaccination patient developed Bell's Palsey. she recovered after a course of steroids.  she does have a history of Bell's Palsey on two other occasions, ten years prior to this particular reaction.
COVID Vaccine - Ffizer - About 1 minute after, got very sweaty & chills, faint and then threw up
I24.8 DEMAND ISCHEMIA 1/31/2023 ATHEROSCLEROSIS OF AORTA J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 7/29/2021 ATHEROSCLEROSIS OF AORTA I24.8 DEMAND ISCHEMIA 1/31/2023 ABNL FASTING GLUCOSE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 7/29/2021 ABNL FASTING GLUCOSE
tired; very sore arm; This is a spontaneous report from a non-contactable consumer (patient). A 69-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EM9809; expiry date: unknown) via an unspecified route of administration in the left arm, on 11Feb2021 at 14:30 at a single dose, for COVID 19 immunization. The patient's medical history and concomitant medications were not reported. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. Facility where vaccine was administered was reported as "other". On 12Feb2021, the patient had a very sore arm. The patient was tired the next day (13Feb2021). The patient did not receive treatment for the events. Outcome of the events was recovered. The patient has not been tested for COVID-19 since vaccination.  No follow-up attempts are possible. No further information is expected.
This patient was to receive the Pfizer bivalent booster but was given a 4th dose of the monovalent vaccine. She had previously received 2 doses of the Moderna vaccine. The patient was appropriately monitored. There were no adverse outcomes.  The nurse was not paying attention and grabbed the incorrect vial from the vaccine refrigerator.
The patient stated that she had not received a vaccine in several years but that the last time she did, she blacked out for maybe 30 seconds and felt dizzy. She states she thinks it was because she did not eat that day and stood up too quickly because she felt ok after. I notified (pharmacist) to be on stand by in case any incidence occurred and we had smelling salts and epipen on hand. I had the patient sit in the vaccine chair afterwards and about 3 minutes later, she started screaming to the top of her lungs that she felt like she was going to die. She screamed that she couldn't breathe and that her chest and head were "killing her". She kept screaming to remove the vaccine out of her arm (the liquid). Her eyes were starting to roll, but I knew she was breathing because she was screaming to not let her die. Her mother was with her and was very nervous and wanted emergency services, so We called 911. I took the girls hands and asked her to look me in the eyes and follow my deep breaths, because I began to think it was more of a panic attack. She followed by breaths and regained some composure but was sweating profusely, so I began fanning her. After a while of talking her through taking deep breaths and assuring her she was breathing and we had emergency services on the way, she began to calm down. EMS showed up about 15-20 minutes later and she declined to go with them. I stayed with the patient the entire time. She did not faint. I believe she just had a panic attack from working herself up about the vaccine. She was a little scared since she had fainted with the last vaccine.
Redness and extreme itching. Have rubbed raw. Been taking benadryl and anti itching cream with no relief
Eye twitching that is not going away. It has been 4 days since I received vaccine.
Pericarditis within 20-30 min of receiving flu vaccine. Vaccine given and pat was near hospital when Sx started. He went to ED. Echo confirmed Dx.
Initial temp 100 degrees F, myalgia, HA approx 4 hours after vaccination. Approx 18 hours after immunization, (L) arm pain, erythema, warmth, edema to PNEUMOVAX site. Developed approx 3 cm dia clear fluid filled blister, approx 4 cm dia induration, pain. Tx cool compress, ibp/TYLENOL as directed - monitor.
Started developing symptoms similar to those when autoimmune hepatitis was diagnosed.  Throbbing liver pain, nausea and stomach and intestinal pain, severe muscle cramping, aching muscles pain, no appetite, headache
pt recv vax & that same day the MD exp achiness, a h/a & devel redness, swelling, soreness & achiness @ the inj site;pt recovered;
After each shot had minor bronchial irritation and low-grade chronic cough. This has continued to the present.
71 y.o. male with history of leukemia who presents accompanied by his son with complaints of 6 week history of generalized weakness worsening over time accompanied by loss of appetite and weight loss. He reports receiving his initial COVID vaccine 6 weeks ago and symptoms began immediately following this. He denies pain or SOB.   Pt with severe protein calorie malnutrition and AML presented with dehydration from MRSA Sepsis. Pt had weakness from dehydration, malnutrition and sepsis. He had a progressive downhill course. His family elected for comfort measures. He died of his illness and was pronounced dead at 4:13AM April 13, 2021
2nd dose received at 11am.   Mild arm soreness immediately after. Remained for 2 days with no increase in severity then dissipated.   Lymphnode discomfort mild beginning 2 hours after vaccination. Remainder for 2 days with increase to medium severity approximately 8 hours after receiving vaccination.   Nuchal rigidity began 8 hours after receiving 2nd dose, mild -> medium severity. Dissipated 1 day after receiving shot.   Mild photosensitivity to light began approx 9 hours after receiving shot. Dissipated by next morning.   9 hours after receiving vaccination, medium fever developed. Baseline temperature is 96.4. At 9 hours after vaccination, developed fever at 99.7*F. At 11 hours after, temperature was 100.9*F, with severe discomfort and body aches / chills. Dissipated by following morning.   Hope this helps. Thank you.
Per diagnosis of medical center on 10/7/18 and Dr. on 10/8/18 patient was diagnosed with an outbreak of shingles. Painful rash is present on both sides of abdomen/torso and legs, and per patient has worsened in the last few days. Patient also said he experienced 24 to 48 hours post-vaccination fatigue and pain/redness at the injection site.
BLOOD CLOTS; BURNING IN THE LEGS; SWELLING IN THE LEGS; TROUBLE WALKING; SHORTNESS OF BREATH; This spontaneous report received from a patient concerned a 74 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: non-alcohol user, smoker (3 cigarettes/day), hypertension, hypothyroidism, and the patient had no known drug allergies. The patient experienced drug abuse when treated with cannabis sativa. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 180270, and expiry: UNKNOWN) dose was not reported, 1 total administered on 09-MAR-2021 for prophylactic vaccination.  Concomitant medications included amlodipine for hypertension, and levothyroxine for hypothyroidism.  On 11-MAR-2021, the patient experienced shortness of breath. On 12-MAR-2021, the patient experienced blood clots. On 12-MAR-2021, the patient experienced burning in the legs. On 12-MAR-2021, the patient experienced swelling in the legs. On 12-MAR-2021, the patient experienced trouble walking. On 13-JAN-2022, the primary care physician (PCP) prescribed ipratropium bromide/salbutamol sulfate (Combivent Respimat) for shortness of breath. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from blood clots, shortness of breath, burning in the legs, swelling in the legs, and trouble walking. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20220126392.; Sender's Comments: V0-20220126621- Covid-19 vaccine ad26.CoV-2.s - Blood clot. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Nov-2021 at 1:35 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-Nov-2021 at 1:35 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided.  The information about allergies, acute illnesses, chronic or long standing health conditions, information about other medications (prescription, OTC, dietary supplements or herbal remedies) at the time of vaccination or at time of reporting were unknown.  The vials underwent temperature excursions for 1 month. The vial was in frozen state at the time of the excursion (Vials in question stored in a super cold freezer) and minimum reached temperature was negative 82 degrees Fahrenheit. The patient was given dose from vial that was stored in an ultracold freezer which was colder than it should have been. The vials were moved from freezer to refrigerator on 19-Nov-2021. No vaccine state changes were noticed. The vaccine was never refrozen. None of the vials were punctured. No previous temperature excursions was reported.  No treatment medications were provided.   This case was linked to MOD-2021-402935 (Patient Link).
Tonight I had a woman call regarding her 58 yo daughter.  She stated that yesterday I gave her the Moderna vaccine and now she has severe facial swelling.   She was wondering if it was related to the vaccination.   I recommended that she go to the emergency room.  She then asked what Keflex was for and that the patient had been receiving for a tooth infection.  She again stated that the facial swelling was severe and I again recommended the emergency room.
25APR94 c/o joint pain lower extremities; 29APR93 noticed face was swollen & thinks had low grade temp; seen by MD 2MAY94;
Around 6 pm the following symptoms started:  Heart rate was as high as 140 Body aches Felt like I had a fever Felt like pressure on chest Arm was very sore Had chills Nauseous
Pt experience syncopal episode (low BP, low HR, diaphoresis, warm sensation, light headedness, dizziness, and nausea after administration of MCV4 MENACTRA and Varicella. VS-212-92/56, 48. 218-100/56, 52. 223-110/60, 68. Ice applied to nape of neck, legs crossed, hand squeezed, remain in clinic 30min.
8-9 days after the first vaccine I had flu-like symptoms. Chills, body aches and headaches. No fever. Lasted for 3 days
11 days after I received the booster shot, I got intense hives. The hives appear, disappear, and reappear somewhere else on my body. They are extremely painful and itchy. They haven't stopped in the past 8 days. I have to take Zytrec and Benedryl and sometimes that doesn't work. They are nonstop.
Mild shoulder pain within a few hours that became worse. Could not move shoulder much by next morning due to pain and weakness. Woke from sleep. Scarf test positive, Hawkins test positive, empty can test negative, no pain along top of shoulder. Diffuse pain around joint, including anterior and posterior to deltoid. Injection appears to have been given too high, less than 2 fingers from acromion process. Pain gradually worse, day 2 with arm in sling. Night 2 hard to find position of comfort and woke frequently, day 3 also arm in sling, some mild improvement in range of motion. Passive rom intact but active rom very painful. Night 3 improvement. Day 4 less painful, night 4 only woke to pain 3-4 times. Day 5 less painful, sling not needed, active rom still reduced. Night 5 sleep unaffected. Day 6 arm much better but still cannot raise over head. Night 6 uneventful. Day 7 almost back to baseline.
Painful rash; painful rash about the arms, upper arms, neck, upper chest, and top of scalp; This case was reported by a pharmacist via call center representative and described the occurrence of painful rash in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of rash (1st dose received on 24th May 2019 (batch number CF9K4, expiry date 11th September 2021), in right arm developed rash, refer case US2019137612.).   On 23rd July 2019, the patient received the 2nd dose of Shingrix. On 27th July 2019, 4 days after receiving Shingrix, the patient experienced painful rash and generalized rash. On an unknown date, the outcome of the painful rash and generalized rash were unknown.   It was unknown if the reporter considered the painful rash and generalized rash to be related to Shingrix.  Additional case details were reported as follows: On 23rd July 2019, the patient received vaccine in unknown arm which led to inappropriate schedule of vaccine administered. The 4 days after vaccination, the patient reported that she developed a painful rash about the arms, upper arms, neck, upper chest, and top of scalp. At time of reporting it was not known what the status of the events were. The reporter also reported that the husband of the patient also reported and event, which would be submitted as a clone to this report. The reporter gave permission to follow up. This case had been linked to the case US2019137612, reported for same patient. This was a medication error with harm.
Hallucinations; Psychological problems/unable to speak for herself; Memory problems/getting lost; Delusions; This spontaneous case was reported by a consumer and describes the occurrence of HALLUCINATION (Hallucinations), MENTAL DISORDER (Psychological problems/unable to speak for herself), MEMORY IMPAIRMENT (Memory problems/getting lost) and DELUSION (Delusions) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Embolic shower (similar to stroke) in 2012 and Accident (Car accident) in 2012. Concomitant products included DULOXETINE HYDROCHLORIDE (CYMBALTA) for an unknown indication.    On 13-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2021, the patient experienced HALLUCINATION (Hallucinations) (seriousness criteria hospitalization and medically significant), MENTAL DISORDER (Psychological problems/unable to speak for herself) (seriousness criterion hospitalization), MEMORY IMPAIRMENT (Memory problems/getting lost) (seriousness criterion hospitalization) and DELUSION (Delusions) (seriousness criterion hospitalization). The patient was hospitalized for 10 days due to DELUSION, HALLUCINATION, MEMORY IMPAIRMENT and MENTAL DISORDER. At the time of the report, HALLUCINATION (Hallucinations), MENTAL DISORDER (Psychological problems/unable to speak for herself), MEMORY IMPAIRMENT (Memory problems/getting lost) and DELUSION (Delusions) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.  Patient's parent reported that patient has been in the hospital for 10 days. Patient was unable to speak for herself after receiving the vaccination. Patient experienced psychological problems within a week after vaccination, which turned out to delusions, hallucinations. Doctors were trying to understand the reactions.  Company Comment: This case concerns a 26 year-old, female subject with a history of Embolic Shower,  who experienced the unexpected events of Hallucinations and Mental Disorder. The event occurred approximately unknown date,  after the first dose of Moderna Covid-19 vaccine.  The medical history, Embolic shower and use of concomitant medication Duloxetine remains a confounder. The benefit-risk relationship of mRNA-1273, is not affected by this report.; Sender's Comments: This case concerns a 26 year-old, female subject with a history of Embolic Shower,  who experienced the unexpected events of Hallucinations and Mental Disorder. The event occurred approximately unknown date,  after the first dose of Moderna Covid-19 vaccine.  The medical history, Embolic shower and use of concomitant medication Duloxetine remains a confounder. The benefit-risk relationship of mRNA-1273, is not affected by this report.
Initial and follow-up information has been received from a physician and a health professional through the Merck pregnancy registry concerning a 25 year old female with no known allergies or adverse drug reactions reported. On 16-NOV-2006, the patient was vaccinated with the first dose of GARDASIL vaccine (yeast). There were no concomitant medications reported. On 09-JAN-2007, the patient was vaccinated with the second 0.5 ml dose of GARDASIL vaccine (yeast). It was reported that the patient had the two shots while pregnant. The patient sought unspecified medical attention. It was reported that the patient planned to have the third shot. Subsequently, the patient experienced Group B streptococcus and trichomoniasis. On 24-JUL-2007 the patient delivered at 39 weeks a normal 6 pound 14 ounce female infant. It was unknown if there were complications during the labor or delivery. The apgar score was 8 and 9. Additional information is not expected.
The night after my injection, when I got out of bed to use the restroom, I fainted and fell to the floor, out cold. This problem repeated itself a number of hours later, only I chose to crawl rather than walk, so I did not actually faint that time, but surely would have if I had stood up. I had a fever at the time and major body aches. The fever started about seven hours after injection. The fainting happened about twelve hours after injection. I sustained minor bodily injuries as a result of the fall, none requiring medical attention. The near-faint was about fourteen hours after injection. I awoke the next morning with the fever nearly gone and felt much better, returning to normal health within 48 hours
Left arm swollen, sore and movement limited within hours after receiving vaccine.  Soreness, severe limitations on ability to lift arm and limitations on range of motion increased over the days and weeks.  Pain was most prominent at night and disrupted sleep.
Child received 4 yr vaccines for school entry on Friday 3/23/07 in our open immunization clinic. Redness, swelling and itching started in Left deltoid area. The next day (Saturday) mother started ice packs and gave Child Tylenol for discomfort for 1 dose. Right exotropia noted in right arm as well. Left arm better per mom today.
This case was reported by a consumer via call center representative and described the occurrence of fatigue in a 66-year-old female patient who received SHINGRIX for prophylaxis. On 23rd August 2018, the patient received the 2nd dose of SHINGRIX (intramuscular). On 24th August 2018, 1 days after receiving SHINGRIX, the patient experienced fatigue, muscle pain, fever and activities of daily living impaired. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the fatigue, muscle pain, fever and activities of daily living impaired were recovering/resolving. It was unknown if the reporter considered the fatigue, muscle pain, fever and activities of daily living impaired to be related to SHINGRIX. Additional details were provided as follows: At 12:00 hours, the patient received SHINGRIX on left arm. The patient stated that, she woke up today (on the date of reporting) with fatigue and muscle ache all over the body. At 10:15 am, she went swimming and once she got home she checked to see that she had fever of 102 degree F. She took a Tylenol and napped for a while. She also had to cancel going to work today (on the date of reporting). The patient had denied permission to contact their physician. No further details were provided.
Red round warm 1 in by 1 in round circumscribed area where immunization was given.